1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparing patterns of recurrence and survival in conventionally fractionated radiation with stereotactic body radiation therapy for early-stage NSCLC
    Meeting Abstract

    Shaikh, F.; Foster, A.; Zhang, Z.; Woo, K.; Din, S. U.; Gelblum, D.; Yorke, E. D.; Rosenzweig, K.; Wu, A. J.; Rimner, A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Novel role for PTEN in regulating non homologous end-joining factor 53BP1 to suppress replication fork instability
    Meeting Abstract

    Schlacher, K.; Guo, W.; Jasin, M.; Wu, H.
    FASEB Journal (2014)

    Fulltext@MSK | Save
  • Epigenetic analysis of small cell lung cancer defines distinct disease subsets
    Meeting Abstract

    Rudin, C. M.; Connis, N.; Hann, C. L.; Poirier, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • First-line monotherapy with nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and correlation of outcomes with PD-L1 status
    Meeting Abstract

    Rizvi, N. A.; Shepherd, F. A.; Antonia, S. J.; Brahmer, J. R.; Chow, L. Q.; Goldman, J.; Juergens, R.; Borghaei, H.; Ready, N. E.; Gerber, D. E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) maintenance as monotherapy or in combination with bevacizumab (BEV) for non-small cell lung cancer (NSCLC) previously treated with chemotherapy
    Meeting Abstract

    Rizvi, N. A.; Antonia, S. J.; Shepherd, F. A.; Chow, L. Q.; Goldman, J.; Shen, Y.; Chen, A. C.; Gettinger, S.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Stage III non-small cell lung cancer treated without concurrent chemotherapy: What is the optimal radiation dose?
    Meeting Abstract

    Rimner, A.; Din, S.; Shaikh, F.; Foster, A.; Tyagi, N.; Abi Aad, S.; Paik, P.; Yorke, E. D.; Chaft, J. E.; Gelblum, D. Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Phase II study of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced, refractory squamous non-small cell lung cancer
    Meeting Abstract

    Ramalingam, S. S.; Mazieres, J.; Planchard, D.; Stinchcombe, T. E.; Dy, G. K.; Antonia, S. J.; Horn, L.; Lena, H.; Minenza, E.; Mennecier, B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • EGFR exon 20 alterations in lung adenocarcinomas and their impact on overall survival and response to EGFR TKI
    Meeting Abstract

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Arcila, M. E.; Yu, H. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save